Charles Faith L. 4

What Happened

• Charles Faith, a director of Abeona Therapeutics, was granted 37,313 shares of restricted common stock on January 26, 2026. The grant price was reported as $0.00 (total value $0 on grant).

Key Details

• Transaction date: 2026-01-26; transaction type: Award/Grant (code A).
• Price per share: $0.00; total consideration reported: $0.
• Vesting: All restricted shares will vest on January 26, 2027 (footnote).
• Shares owned after the transaction: not specified in the Form 4 filing.
• Filing date: 2026-01-27 (filed the day after the grant; not indicated as late).

Context

• This was a restricted stock award (compensation), not an open-market purchase or sale. Such awards are commonly used for director compensation and do not by themselves indicate a buy or sell signal. The shares are subject to vesting until Jan 26, 2027; ownership and potential sale rights may be limited until vesting.